Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -9 of 9
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Title
Phase
Protocol IDs
Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
Phase II, Phase I
UCSF-04458
NCT00227617
Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors
Phase II, Phase I
CTCT 06-11
NCT00493883
Lithium for Low-Grade Neuroendocrine Tumors
Phase II
CO07203
NIH R21CA117117-01A2, NCT00501540
Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors
Phase II
SOR-NET-001
NCT00605566
Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma
Phase II
2006-0954
NCT00607113
Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)
Phase II
07-162
NCT00610129
The Safety and Efficacy of CPTK787/ZK222584 in Patients With Metastatic Neuroendocrine Tumors
Phase II
CPTK787/ZK222584
NCT00627198
Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors
Phase I
NCI-07-C-0047
NCI-P6880, NCT00436735
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Phase I
MAYO-MC0414
MC0414, NCT00655655
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute